Net Cash Provided by (Used in) Operating Activities |
-1.91M |
USD |
-134% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
90.1M |
USD |
+819309% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-87.3M |
USD |
-107690% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
50M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
13.9M |
shares |
+93% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
919K |
USD |
-83.5% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
13.6M |
USD |
+82.4% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Valuation Allowance |
936K |
USD |
|
Q3 2024 |
Q3 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Gross |
3.21M |
USD |
+7.04% |
Q4 2024 |
FY 2024 |
Operating Lease, Liability |
24K |
USD |
-79.3% |
Q2 2025 |
Q2 2025 |
Payments to Acquire Property, Plant, and Equipment |
4K |
USD |
-95.8% |
Q1 2024 |
Q1 2025 |
Lessee, Operating Lease, Liability, to be Paid |
24K |
USD |
-79.7% |
Q2 2025 |
Q2 2025 |
Operating Lease, Liability, Current |
24K |
USD |
-73.9% |
Q2 2025 |
Q2 2025 |
Lessee, Operating Lease, Liability, to be Paid, Year Two |
71K |
USD |
-23.7% |
Q4 2023 |
FY 2023 |
Lessee, Operating Lease, Liability, to be Paid, Year One |
71K |
USD |
-23.7% |
Q4 2024 |
FY 2024 |
Deferred Income Tax Expense (Benefit) |
-10.3M |
USD |
-7462% |
Q1 2025 |
Q1 2025 |
Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
1K |
USD |
-66.7% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
185K |
USD |
-1.6% |
Q4 2024 |
FY 2024 |
Unrecognized Tax Benefits |
465K |
USD |
-19.8% |
Q2 2025 |
Q2 2025 |
Additional Paid in Capital |
280M |
USD |
+2143% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
3.21M |
USD |
+7.04% |
Q4 2024 |
FY 2024 |
Share-based Payment Arrangement, Expense |
3.95M |
USD |
+944% |
Q2 2025 |
Q2 2025 |